Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N. Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L. McMorrow, Kathleen Kahn, F. Xavier Gómez-Olivé, Stephen Tollman, Neil A. Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen, for the PHIRST-C Group
doi: https://doi.org/10.1101/2021.05.26.21257849
Jackie Kleynhans
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(MPH)Stefano Tempia
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
3Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
(PhD)Nicole Wolter
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
4School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Anne von Gottberg
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
4School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Jinal N. Bhiman
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
4School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Amelia Buys
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MTech)Jocelyn Moyes
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(MD)Meredith L. McMorrow
3Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
5Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa
(MD)Kathleen Kahn
6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)F. Xavier Gómez-Olivé
6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Stephen Tollman
6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Neil A. Martinson
7Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa
8Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America
(MD)Floidy Wafawanaka
6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(MSc)Limakatso Lebina
7Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa
(MD)Jacques du Toit
6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(MD)Waasila Jassat
9Division of Public Health Surveillance and Response, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MD)Mzimasi Neti
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
(MPH)Marieke Brauer
10Immunology Department, National Reference Laboratory, Ampath Pathology, Pretoria, South Africa
(MMed Path)Cheryl Cohen
1Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(PhD)Data Availability
The investigators welcome enquiries about possible collaborations and requests for access to the dataset. Data will be shared after approval of a proposal and with a signed data access agreement. Investigators interested in more details about this study, or in accessing these resources, should contact the corresponding author.
Posted May 29, 2021.
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N. Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L. McMorrow, Kathleen Kahn, F. Xavier Gómez-Olivé, Stephen Tollman, Neil A. Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen, for the PHIRST-C Group
medRxiv 2021.05.26.21257849; doi: https://doi.org/10.1101/2021.05.26.21257849
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N. Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L. McMorrow, Kathleen Kahn, F. Xavier Gómez-Olivé, Stephen Tollman, Neil A. Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen, for the PHIRST-C Group
medRxiv 2021.05.26.21257849; doi: https://doi.org/10.1101/2021.05.26.21257849
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2831)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12530)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2837)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4165)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6750)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)